Regarding choledochal cysts following features are true except:
In Pringle Manoeuvre, clamping includes which of the following? 1. Common Bile Duct 2. Hepatic artery 3. Portal vein 4. Inferior Vena Cava
A patient is found to have an asymptomatic common bile duct (CBD) stone two years after cholecystectomy on routine imaging. What is the most appropriate initial management?
The following procedure is performed for the management of?

Most common type of choledochal cyst is:
A 52-year-old woman presents with jaundice, pale stools, and a palpable gallbladder. MRCP shows a dilated bile duct but no stones. What is the next best step?
A 45-year-old woman presents with right upper quadrant pain and fever. Ultrasound reveals gallstones with dilation of the bile ducts. What is the most appropriate next step?
What is the first-line diagnostic method for cholecystitis?
A 60-year-old male with a history of cirrhosis presents with a 4 cm hepatocellular carcinoma (HCC) located in segment VII of the liver. Considering the patient has Child-Pugh A liver function, which clinical factors are most critical in deciding between liver resection and radiofrequency ablation (RFA)?
Which anatomical division of the liver is typically used to describe the location of lesions for surgical planning?
Explanation: **_Older presentations have an acquired variant_** - Choledochal cysts are universally considered **congenital anomalies** due to an anomalous pancreaticobiliary junction, even if presenting later in life. They are not typically classified into acquired and congenital variants. - While some theories suggest a role for acquired inflammation or obstruction in their development or progression, the underlying predisposition is congenital. *Increased risk of cholangiocarcinoma in older presentations* - The risk of **cholangiocarcinoma** is significantly elevated in patients with choledochal cysts, and this risk increases with age. - Prophylactic excision is recommended due to this malignant potential, particularly in older individuals. *Congenital cysts* - Choledochal cysts are indeed **congenital malformations** of the bile ducts, characterized by cystic dilation of any part of the biliary tree. - The fundamental defect is believed to be an **anomalous pancreaticobiliary junction (APBJ)**, leading to reflux of pancreatic enzymes into the bile duct. *60% are diagnosed before 10 years* - A significant proportion of choledochal cysts are diagnosed in **childhood**, with approximately 60% of cases identified before the age of 10 years. - However, around 20% of cases are diagnosed in adulthood, often presenting with complications.
Explanation: ***1, 2 and 3*** - The **Pringle maneuver** involves clamping structures within the **hepatoduodenal ligament** to temporarily control bleeding from the liver. - The three main structures within the hepatoduodenal ligament that are clamped are the **hepatic artery**, the **portal vein**, and the **common bile duct**. *2, 3 and 4* - This option incorrectly includes the **inferior vena cava (IVC)**, which is not part of the hepatoduodenal ligament and therefore not clamped during a standard Pringle maneuver. - Clamping the IVC would lead to severe hemodynamic instability and is not a part of this routine surgical maneuver. *1, 3 and 4* - This option incorrectly includes the **inferior vena cava (IVC)**, which is not clamped during the Pringle maneuver. - It also omits the **hepatic artery**, a major blood supply to the liver, which must be clamped along with the portal vein to effectively reduce hepatic blood flow. *1, 2 and 4* - This option incorrectly includes the **inferior vena cava (IVC)**, which is located posterior to the liver and not within the hepatoduodenal ligament. - It also omits the **portal vein**, which contributes to the majority of the liver's blood supply and is crucial to occlude during the Pringle maneuver to control bleeding effectively.
Explanation: ***ERCP with sphincterotomy and stone extraction*** - This is the **gold standard management** for CBD stones discovered after cholecystectomy, even when asymptomatic - **Post-cholecystectomy CBD stones will not pass spontaneously** as there is no gallbladder to contract and propel stones forward - The **risk of complications** (acute cholangitis, acute pancreatitis, biliary obstruction) from leaving the stone in place outweighs the risk of ERCP - ERCP has a **high success rate (>90%)** with acceptable complication rates (pancreatitis 3-5%, bleeding <1%, perforation <1%) - **Prophylactic stone removal** prevents future emergency presentations and allows for planned intervention under optimal conditions *Keep on active surveillance* - **Not appropriate** for CBD stones in post-cholecystectomy patients, as these stones will not pass spontaneously - Unlike gallbladder stones, CBD stones carry a **significant risk of serious complications** including ascending cholangitis and acute biliary pancreatitis - Active surveillance might be considered only in patients with **prohibitive surgical risk** or very limited life expectancy - Modern guidelines recommend **intervention for all CBD stones** found post-cholecystectomy regardless of symptoms *Surgical exploration and choledochotomy* - This is a more **invasive approach** with higher morbidity compared to ERCP - Reserved for cases where **ERCP fails or is not feasible** (altered anatomy, large impacted stones, intrahepatic stones) - Not appropriate as **initial management** when less invasive endoscopic options are available - May be considered if ERCP is unsuccessful after 1-2 attempts *Medical dissolution therapy with ursodeoxycholic acid* - **Ineffective for CBD stones** - UDCA works only for small cholesterol stones in a functioning gallbladder - Requires months to years of therapy with **poor success rates** even for gallbladder stones - **Not recommended** for choledocholithiasis in any clinical scenario - This patient has already undergone cholecystectomy, making dissolution therapy completely irrelevant
Explanation: ***Distal cholangiocarcinoma*** - The image shows a **Pylorus-preserving Whipple procedure (PPPD)**, which involves resection of the pancreatic head, duodenum, gallbladder, and part of the common bile duct, followed by reconstruction. - This procedure is primarily performed for malignancies of the **pancreatic head**, **distal bile duct (cholangiocarcinoma)**, and **ampulla of Vater**, as they often cause obstructive jaundice and are resectable. *Gallbladder carcinoma* - While gallbladder carcinoma can involve the bile ducts, this specific reconstruction (PPPD) is more commonly associated with tumors of the pancreatic head or distal bile duct rather than the gallbladder itself, which might be managed with a **cholecystectomy** and possibly **liver resection**. - The type of resection and reconstruction varies significantly based on the extent and location of gallbladder cancer. *Chronic calcific pancreatitis* - Surgical management for chronic pancreatitis, especially with calcifications, typically involves drainage procedures (e.g., **Puestow procedure** due to dilated pancreatic duct or **Frey procedure**) or resection of the pancreatic head (e.g., **Beger procedure**). - While some resections of the pancreatic head are performed for chronic pancreatitis, the depicted procedure is specifically designed for malignancies of the pancreatic head region, not primarily for the sequelae of chronic calcific pancreatitis unless associated with a mass suspicious for malignancy. *Advanced gastric carcinoma* - Advanced gastric carcinoma is typically managed by **gastrectomy** (partial or total) with lymphadenectomy, not a Whipple procedure. - The image clearly shows an **intact pylorus** and the stomach mostly preserved, which is inconsistent with advanced gastric carcinoma requiring major gastric resection.
Explanation: ***Type I*** - **Type I choledochal cyst** is the most common type, accounting for **80-90%** of all cases. - It involves a **fusiform dilatation** of the extrahepatic bile duct. *Type II* - **Type II choledochal cysts** are rare and present as a **diverticulum** arising from the common bile duct. - This type has a very different morphological appearance compared to the more common fusiform dilatation. *Type III* - **Type III choledochal cysts**, also known as **choledochoceles**, are dilatations within the duodenal wall near the **ampulla of Vater**. - They are much less common than Type I cysts and have a distinct anatomic location. *Type IV* - **Type IV choledochal cysts** involve **multiple dilatations** of the bile ducts, which can be extrahepatic, intrahepatic, or both. - While more complex, they are less prevalent than the single, fusiform dilatation seen in Type I cysts.
Explanation: ***CT scan of the abdomen*** - The combination of **jaundice**, **pale stools**, a **palpable gallbladder**, and a **dilated bile duct without stones** (Courvoisier's sign) strongly suggests an obstructing mass in the head of the pancreas or distal common bile duct. - A **CT scan of the abdomen** is the initial investigation of choice to visualize and stage potential pancreatic or biliary malignancies. *Liver biopsy* - A liver biopsy is typically performed to evaluate **parenchymal liver disease** or unexplained liver enzyme elevations, not primarily for obstructive jaundice. - It would not identify the cause of the obstruction in the bile duct. *ERCP with biopsy* - **ERCP (Endoscopic Retrograde Cholangiopancreatography)** is both diagnostic and therapeutic, often used to retrieve stones or place stents. - While it could provide a biopsy, it is a more invasive procedure and usually reserved after less invasive imaging like CT has localized the likely obstruction. *Cholecystectomy* - **Cholecystectomy (gallbladder removal)** is indicated for symptomatic gallstones or gallbladder polyps. - In this case, the problem is not within the gallbladder itself, but rather an obstruction of the common bile duct, indicated by the dilated bile duct and absence of stones.
Explanation: ***Endoscopic retrograde cholangiopancreatography (ERCP)*** - This patient presents with symptoms and ultrasound findings suggestive of **acute cholangitis** (right upper quadrant pain, fever, dilated bile ducts, gallstones), which requires **urgent biliary decompression**. - **ERCP with sphincterotomy and stone extraction or stent placement** is the most appropriate next step to relieve the obstruction and treat the infection. *Percutaneous cholecystostomy* - This procedure involves placing a drain into the gallbladder percutaneously and is generally reserved for **critically ill patients** with acute cholecystitis who are not surgical candidates. - While it can drain the gallbladder, it does not address the **common bile duct obstruction** indicated by dilated bile ducts. *Cholecystectomy* - **Cholecystectomy** is the definitive treatment for gallstones and acute cholecystitis, but it is typically performed **after the acute infection and obstruction are resolved**. - Performing cholecystectomy during active cholangitis carries a **higher risk of complications**. *Intravenous antibiotics* - **Intravenous antibiotics** are a crucial component of treating acute cholangitis, but they are **not sufficient on their own** if a biliary obstruction is present. - Antibiotics should be administered, but **biliary decompression** is necessary to prevent worsening sepsis.
Explanation: ***Abdominal ultrasound*** - An **abdominal ultrasound** is the preferred first-line diagnostic modality for cholecystitis due to its **high sensitivity** and specificity, non-invasiveness, and cost-effectiveness. - It can effectively visualize **gallstones**, gallbladder wall thickening, **pericholecystic fluid**, and a positive **sonographic Murphy's sign**. *CT scan* - While a **CT scan** can show signs of cholecystitis, it is generally reserved for cases where the diagnosis is uncertain or to rule out complications and alternative diagnoses. - It involves **ionizing radiation** and is typically not the initial imaging choice over ultrasound for suspected cholecystitis. *MRI* - An **MRI (Magnetic Resonance Imaging)** offers excellent soft tissue contrast but is more expensive, less readily available, and takes longer to perform than ultrasound. - It is typically utilized for more complex cases or when there is suspicion of **biliary obstruction** or other hepatobiliary pathologies not well-visualized by ultrasound. *ERCP* - **ERCP (Endoscopic Retrograde Cholangiopancreatography)** is an invasive procedure with therapeutic capabilities, primarily used for diagnosing and treating **biliary tract obstruction** or cholangitis. - It carries risks such as **pancreatitis** and is not used as a primary diagnostic tool for acute cholecystitis unless there's concern for choledocholithiasis or other complications requiring intervention.
Explanation: ***Tumor size, location, liver function, and portal hypertension status*** - **Tumor size and location** are critical for resectability and RFA feasibility, as HCCs larger than 3-5 cm or located near major vessels/bile ducts may be harder to ablate or resect safely. - **Liver function (Child-Pugh A)** helps assess the liver's reserve to tolerate resection, while the presence of **portal hypertension** indicates a higher risk of post-resection liver decompensation, favoring RFA. *Presence of comorbidities and performance status* - While important for overall surgical risk assessment (ASA score), **comorbidities** and **performance status** are general considerations and not the primary factors differentiating between liver resection and RFA for HCC in a patient with good liver function. - These factors influence the patient's ability to undergo any intervention, but they don't directly guide the choice between a local ablative therapy and surgical removal based on tumor or liver characteristics. *Tumor vascular invasion and metastasis* - The presence of **vascular invasion** or **distant metastasis** generally indicates advanced disease, precluding both curative resection and RFA, pushing towards systemic therapies or palliative care. - These are factors that determine if **curative treatment** is an option at all, rather than helping to choose between two curative local treatments (resection vs. RFA). *Patient’s age and overall health status* - **Age** is less of a direct contraindication for either procedure in itself, especially in a 60-year-old with Child-Pugh A, as physiological age and performance status are more relevant than chronological age. - While **overall health status** is considered, it overlaps with comorbidities and performance status and is not as discriminative as tumor-specific factors or liver physiology in choosing between resection and RFA for HCC.
Explanation: ***Couinaud segments*** - The **Couinaud classification** divides the liver into eight surgically resectable segments, each with its own vascular inflow, outflow, and biliary drainage. - This system is crucial for **surgical planning** and resection of liver tumors, allowing for precise removal of diseased tissue while preserving healthy liver function. *Lobes* - The liver is traditionally divided into **four lobes** (right, left, caudate, and quadrate) based on external anatomical landmarks. - This lobar division does not accurately reflect the intrahepatic vascular and biliary anatomy crucial for surgical resections. *Anatomical regions* - This term is too **vague** and not a recognized, standardized anatomical division used for precise surgical planning in the liver. - It lacks the **detailed vascular and biliary anatomical information** that surgeons require for segmentectomy or other partial hepatectomies. *Functional areas* - While the liver has different functional areas at a microscopic level (e.g., zones around the central vein), this term does not refer to a standardized **macroscopic anatomical division** used for surgical guidance. - **Functional areas** do not correspond to resectable units defined by vascular supply and drainage.
Liver Anatomy and Physiology
Practice Questions
Benign Liver Lesions
Practice Questions
Liver Abscess
Practice Questions
Hepatocellular Carcinoma
Practice Questions
Metastatic Liver Disease
Practice Questions
Cirrhosis and Portal Hypertension
Practice Questions
Liver Trauma
Practice Questions
Cholelithiasis and Cholecystitis
Practice Questions
Choledocholithiasis
Practice Questions
Biliary Tract Tumors
Practice Questions
ERCP and Its Complications
Practice Questions
Liver Transplantation Basics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free